Gilgamesh Pharma | RoundOS

Weekly digest by email

Loading companies…

Gilgamesh Pharma | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 24, 2026	Series A	$60M	Prime Movers Lab — Role not disclosedSatori Neuro — Role not disclosed

Investors

Prime Movers LabSeries A Satori NeuroSeries A

Coverage

Mar 24, 2026Gilgamesh Pharma · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

gilgameshpharmaceutical.com ↗